- Home
- RGEN vs EHC Comparison
RGEN vs EHC Comparison
Compare RGEN & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- EHC
- Stock Information
- Founded
- RGEN 1981
- EHC 1983
- Country
- RGEN United States
- EHC United States
- Employees
- RGEN N/A
- EHC N/A
- Industry
- RGEN Medical/Dental Instruments
- EHC Hospital/Nursing Management
- Sector
- RGEN Health Care
- EHC Health Care
- Exchange
- RGEN Nasdaq
- EHC Nasdaq
- Market Cap
- RGEN 8.2B
- EHC 9.4B
- IPO Year
- RGEN N/A
- EHC 1986
- Fundamental
- Price
- RGEN $145.78
- EHC $92.05
- Analyst Decision
- RGEN Buy
- EHC Strong Buy
- Analyst Count
- RGEN 10
- EHC 7
- Target Price
- RGEN $188.38
- EHC $99.14
- AVG Volume (30 Days)
- RGEN 815.6K
- EHC 413.6K
- Earning Date
- RGEN 10-29-2024
- EHC 10-24-2024
- Dividend Yield
- RGEN N/A
- EHC 0.74%
- EPS Growth
- RGEN N/A
- EHC 25.88
- EPS
- RGEN N/A
- EHC 3.92
- Revenue
- RGEN $602,354,000.00
- EHC $5,070,900,000.00
- Revenue This Year
- RGEN $0.08
- EHC $11.83
- Revenue Next Year
- RGEN $12.97
- EHC $9.01
- P/E Ratio
- RGEN N/A
- EHC $23.51
- Revenue Growth
- RGEN N/A
- EHC 10.86
- 52 Week Low
- RGEN $110.45
- EHC $57.55
- 52 Week High
- RGEN $211.13
- EHC $94.59
- Technical
- Relative Strength Index (RSI)
- RGEN 50.39
- EHC 53.84
- Support Level
- RGEN $135.88
- EHC $90.72
- Resistance Level
- RGEN $150.72
- EHC $94.59
- Average True Range (ATR)
- RGEN 5.37
- EHC 1.72
- MACD
- RGEN -0.37
- EHC -0.16
- Stochastic Oscillator
- RGEN 58.10
- EHC 38.94
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.